Showing results (1-10 of 398) with videos related to
Sort By:
Pageof 40
Medical and Pediatric Oncology|January 1, 1996
Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observationsC Canpolat, P Pearson, R Robertson, et al.Medical and Pediatric Oncology|April 1, 1995
Wilms' tumor: cure of malignant pleural effusion exclusively with chemotherapyC Canpolat, N JaffeCancer|April 15, 1996
Localized cisplatin hyperpigmentation induced by pressure. A case reportZ Al-Lamki, P Pearson, N JaffeInternational Journal of Oncology|May 17, 2011
Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdpN Jaffe, D Jaffe, A Raymond, et al.Clinical Orthopaedics and Related Research|May 16, 2000
Osteosarcoma in preadolescent patientsM Rytting, P Pearson, A K Raymond, et al.Oncology Reports|April 11, 2001
Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedulesS G Berrak, M S Ewer, N Jaffe, et al.Cancer Treatment and Research|January 1, 1993
Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issuesN JaffeThe American Journal of Pediatric Hematology/Oncology|January 1, 1987
Biological consequences of cancer and its treatment and their relationship to current treatment planningN JaffePageof 40